Cargando…
Oral Levosimendan Increases Cerebral Blood Flow Velocities in Patients with a History of Stroke or Transient Ischemic Attack: A Pilot Safety Study
BACKGROUND: Intravenous levosimendan is indicated for acute heart failure. The compound has shown promising beneficial effects in ischemic stroke models. OBJECTIVE: We evaluated the efficacy and safety of oral levosimendan in patients with a history of cerebral ischemia. METHODS: In a randomized, do...
Autores principales: | Kivikko, Matti, Kuoppamäki, Mikko, Soinne, Lauri, Sundberg, Stig, Pohjanjousi, Pasi, Ellmen, Juha, Roine, Risto O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4461857/ https://www.ncbi.nlm.nih.gov/pubmed/26082815 http://dx.doi.org/10.1016/j.curtheres.2015.01.001 |
Ejemplares similares
-
Increased dose of carbidopa with levodopa and entacapone improves “off” time in a randomized trial
por: Trenkwalder, Claudia, et al.
Publicado: (2019) -
Repetitive levosimendan treatment in the management of advanced heart failure
por: Oliva, Fabrizio, et al.
Publicado: (2018) -
Transient ischemic attacks: predictability of future ischemic stroke or transient ischemic attack events
por: Gupta, Harsh V, et al.
Publicado: (2014) -
Differentiation of true transient ischemic attack versus transient ischemic attack mimics
por: Noureddine, Ali, et al.
Publicado: (2014) -
Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers
por: Bergh, Claes-Håkan, et al.
Publicado: (2010)